Methodology-centered review of molecular modeling, simulation, and prediction of SARS-CoV-2

K Gao, R Wang, J Chen, L Cheng, J Frishcosy… - Chemical …, 2022 - ACS Publications
Despite tremendous efforts in the past two years, our understanding of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), virus–host interactions, immune …

The effect of various compounds on the COVID mechanisms, from chemical to molecular aspects

S Mahmoudi, MM Dehkordi, MH Asgarshamsi - Biophysical Chemistry, 2022 - Elsevier
The novel coronavirus that caused COVID-19 pandemic is SARS-CoV-2. Although various
vaccines are currently being used to prevent the disease's severe consequences, there is …

[HTML][HTML] In-silico investigation of phenolic compounds from leaves of Phillyrea angustifolia L. as a potential inhibitor against the SARS-CoV-2 main protease (Mpro …

A Boufissiou, M Abdalla, M Sharaf… - Journal of Saudi …, 2022 - Elsevier
There is currently a global COVID-19 pandemic caused by the severe acute respiratory
syndrome Coronavirus-2 (SARS-CoV-2) and its variants. This highly contagious viral …

Potential targets of severe acute respiratory syndrome coronavirus 2 of clinical drug fluvoxamine: docking and molecular dynamics studies to elucidate viral action

SK Panda, PSS Gupta, MK Rana - Cell Biochemistry and …, 2023 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has continued evolving for
survival and adaptation by mutating itself into different variants of concern, including …

Exploring the potential of fluoro‐flavonoid derivatives as anti‐lung cancer agents: DFT, molecular docking, and molecular dynamics techniques

NJI Esha, ST Quayum, MZ Saif… - … Journal of Quantum …, 2024 - Wiley Online Library
The present investigation utilized in silico methodologies to explore the diverse
pharmacological activities, toxicity profiles, and chemical reactivity of a series of fluoro …

[HTML][HTML] Zanamivir and baloxavir combination to cure persistent influenza and coronavirus infections after hematopoietic stem cell transplant

V Euzen, A Xhaard, S Berreira-Ibraim, L Deville… - International Journal of …, 2024 - Elsevier
Objectives Immunocompromised patients may experience prolonged shedding of influenza
virus potentially leading to severe infections. Alternatives to monotherapy with …

Computational Screening of Inhibitory Compounds for SARS-Cov-2 3CL Protease with a Database Consisting of Approved and Investigational Chemicals

K Miwa, Y Guo, M Hata, N Yamamoto… - Chemical and …, 2023 - jstage.jst.go.jp
Computational screening is one of the fundamental techniques in drug discovery. Each
compound in a chemical database is bound to the target protein in virtual, and candidate …

Emden: A novel method integrating graph and transformer representations for predicting the effect of mutations on clinical drug response

Z Liu, Y Bao, W Wang, L Pan, H Wang… - Computers in Biology and …, 2023 - Elsevier
Precision medicine based on personalized genomics provides promising strategies to
enhance the efficacy of molecular-targeted therapies. However, the clinical effectiveness of …

Genotyping, in silico screening and molecular dynamics simulation of SNPs of MGMT and ERCC1 gene in lung cancer patients treated with platinum-based doublet …

S Singh, A Gupta, N Singh, PS Sengupta… - Journal of …, 2023 - Taylor & Francis
Lung cancer, the leading cause of death worldwide, arises from an intricate combination of
genetic and environmental factors. Genetic variations can influence the chemotherapeutic …

3-Chymotrypsin-like Protease (3CLpro) of SARS-CoV-2: Validation as a Molecular Target, Proposal of a Novel Catalytic Mechanism, and Inhibitors in Preclinical and …

VMF Amorim, EP Soares, ASA Ferrari, DGS Merighi… - Viruses, 2024 - mdpi.com
Proteases represent common targets in combating infectious diseases, including COVID-19.
The 3-chymotrypsin-like protease (3CLpro) is a validated molecular target for COVID-19 …